Fierce Healthcare January 18, 2022
Rebecca Torrence

Kidney care giant DaVita has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates.

MedSleuth’s products won’t be used by DaVita’s providers or at its clinics, which don’t offer transplants. They’ll continue to be used by MedSleuth clients at transplant centers across the country. The acquisition will bolster DaVita’s portfolio of efforts in kidney care, despite not integrating directly with its primary business.

The company declined to disclose the financial terms of the deal.

Seeking a kidney or liver transplant can be a long and arduous process for patients, complicated by a lack of supply and the difficulty of finding a compatible donor.

MedSleuth offers software solutions to help improve that process for patients,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Provider, Trends
Opinion: The world is relying on the United States to get value-based drug pricing right
Retail giants can’t figure out health care
If AI Harms A Patient, Who Gets Sued?
Stranded in the ER, Seniors Await Hospital Care and Suffer Avoidable Harm
Thousands believe they suffered serious side effects from COVID-19 vaccines

Share This Article